How to investigate the microbiome?

Investigating the microbiome involves combining careful sampling, modern sequencing, and thoughtful interpretation to understand how microbial communities influence health. This post explains practical methods for studying the gut microbiome, outlines types of tests and sequencing options, and guides you in interpreting community profiles to support personalized interventions. It answers key questions such as which tests are appropriate, how sequencing technologies differ, how to choose reliable services, and how to translate results into probiotic, prebiotic, and lifestyle strategies. This overview is useful for researchers, clinicians, and informed consumers who want actionable, science-based approaches to microbiome investigation.

Understanding the Microbiome: Unlocking the Secrets of Your Gut Health

The term microbiome refers to the full collection of microorganisms — bacteria, archaea, viruses, fungi and their genes — that live in and on a host, interacting with each other and the host’s cells. In humans, the gut microbiome is the densest and most metabolically active microbial ecosystem, playing essential roles in digestion, nutrient absorption, synthesis of vitamins (for example, vitamin K and certain B vitamins), protection against pathogens through colonization resistance, modulation of the immune system, and production of bioactive metabolites such as short-chain fatty acids (SCFAs), neurotransmitter precursors, and bile acid derivatives. Understanding the gut microbiome helps explain inter-individual differences in drug metabolism, dietary responses, inflammation, and even behavior and mood via the microbiota–gut–brain axis. Investigating the microbiome is therefore relevant not only to gastroenterology but also to metabolic disease, allergy, autoimmunity, mental health, and healthy aging. When you investigate the microbiome you are essentially characterizing a dynamic ecological community: what taxa are present, how abundant they are, what genes and metabolic potentials they carry, how they interact with the host, and how stable or resilient the community is over time. A well-designed investigation begins with clear questions: Are you diagnosing dysbiosis associated with symptoms? Tracking longitudinal changes after an intervention? Identifying taxa associated with a clinical outcome or phenotype? Different objectives require different sampling strategies, laboratory methods, and analytic approaches. For consumer-oriented testing the focus is often on taxonomic composition and broad diversity metrics, while research-grade work adds metagenomic, metatranscriptomic, metabolomic, or culture-based methods. The gut microbiome is also influenced by diet, medications (especially antibiotics and proton pump inhibitors), environment, exercise, sleep, age, and host genetics, which means interpretation must account for lifestyle and clinical context. Investigating the microbiome can inform personalized health strategies, such as targeted dietary adjustments, tailored probiotic or prebiotic choices, or monitoring the effect of specific therapies. However, investigators must be cautious: associations do not prove causation, and many reported links are still being validated in rigorously controlled human trials. Ethical considerations include informed consent, data privacy, and clear communication about what test results can — and cannot — tell you. For consumers seeking accessible testing, reputable services such as clinically oriented stool microbiome tests provide actionable summaries, and products like the InnerBuddies gut microbiome test are positioned to offer user-friendly sampling and analysis options. Properly conducted, microbiome investigation is a powerful tool for unlocking individualized insights into gut health, guiding evidence-based interventions, and contributing to a growing body of translational research.

Microbiome Analysis: The First Step in Deciphering Your Gut Ecosystem

Microbiome analysis starts with sample collection and proceeds through laboratory processing, sequencing or targeted assays, and bioinformatic interpretation. The most common sample type for gut microbiome studies is a stool specimen because it captures the luminal community, microbial DNA shed from intestinal surfaces, and metabolic byproducts. Other sampling options — mucosal biopsies, rectal swabs, or ileostomy fluid — can provide different views of the microbiome but are more invasive. For routine investigation, stool-based testing strikes a balance between accessibility and biological relevance. Key analytical approaches include targeted marker gene sequencing (commonly 16S ribosomal RNA gene sequencing for bacteria), shotgun metagenomic sequencing (sequencing all DNA in a sample to capture species-level composition and gene content), quantitative PCR (qPCR) for specific organisms or functional genes, and culture-based or culturomics methods for isolating live strains. Metabolomic profiling complements DNA-based methods, measuring bioactive compounds, SCFAs, bile acids, and other small molecules produced by microbes and host tissues — essential for linking taxa to function. Many consumer and clinical services provide standardized stool kits with clear instructions to ensure sample stability; some include ambient temperature stabilization buffers to preserve DNA and metabolites during shipping. Choosing the right test depends on the question: if you want an overview of community composition and diversity, a 16S or consumer microbiome test may suffice; if you need functional gene content, antibiotic resistance profiling, or strain-level resolution, shotgun metagenomics or targeted gene panels are preferred. Interpretation of microbiome analysis requires understanding of diversity metrics: alpha diversity (diversity within a sample) and beta diversity (comparative differences between samples). Lower alpha diversity has been associated with some disease states, but context matters — high diversity is not universally “better.” Taxonomic composition is interpreted alongside metadata (diet, medications, recent illness) to avoid misattribution. Ethical considerations are critical: data privacy, potential for incidental findings (for instance, detection of pathogens), and limitations of clinical actionability must be communicated. Selecting a reputable lab means checking for validated sample handling, transparent methods (which sequencing platform, which region of 16S if used), and robust bioinformatics pipelines. Look for services that provide raw data access, clear reports that include limitations, and options to consult with a clinician or specialist for clinical interpretation. If you are considering purchasing a consumer test, consider a scientifically oriented product such as the InnerBuddies microbiome test, which simplifies sample collection and aims to provide interpretable results for lifestyle and dietary decisions. Ultimately, microbiome analysis is the first practical step in decoding a complex ecosystem and should be planned with clear objectives, methodological awareness, and attention to privacy and clinical context.

Gut Microbiome Research: Advancements and Insights into Microbial Dynamics

Gut microbiome research has advanced rapidly due to cheaper sequencing, improved computational methods, and large cohort studies linking microbiome variation to health outcomes. Landmark findings include the role of microbiota in fermenting dietary fibers into SCFAs such as butyrate, acetate and propionate — molecules that nourish colonocytes, modulate inflammation, and influence systemic metabolism. Research also highlights how gut microbes transform bile acids, affecting lipid digestion and host signaling via nuclear receptors like FXR and TGR5. Associations have been established between dysbiosis and conditions such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), obesity, type 2 diabetes, colorectal cancer, and certain neurological conditions. However, the field is moving beyond simple association studies into causal investigations using gnotobiotic animal models, fecal microbiota transplantation (FMT), and tightly controlled dietary intervention trials. These approaches test whether altering the microbiome can change disease phenotypes. Personalized nutrition is an emerging trend where microbiome signatures predict glycemic responses to foods, enabling tailored dietary recommendations. Likewise, microbiome-informed drug therapy is gaining traction: certain microbes metabolize drugs (e.g., inactivation of cardiac glycosides), and resistance genes in the gut reservoir can influence antibiotic stewardship. Recent research also documents bidirectional communication between the gut and the brain, with microbial metabolites and immune mediators implicated in mood, cognition, and stress responses. Advances in multi-omics — integrating metagenomics with metatranscriptomics, proteomics, metabolomics, and host genomics — provide richer functional context but require sophisticated analysis. Large consortia and longitudinal cohorts are improving reproducibility by controlling for confounders such as diet, geography, and medications. Emerging trends include the study of virome and mycobiome components, the role of early life microbial colonization in immune development, and the microbiome’s impact on immunotherapy outcomes in oncology. For investigators and consumers alike, staying current with literature is important because interpretation evolves as new mechanistic data appear. When translating research into action, apply caution: promising associations don’t always yield effective interventions, and product claims should be evaluated against randomized clinical trial evidence. For practical consumer decisions, validated testing and evidence-based interventions — including targeted probiotics or dietary fiber modifications — offer reasonable, low-risk starting points. The InnerBuddies gut microbiome test can be a part of this translational pathway, giving users baseline data to compare against research-driven recommendations or to monitor changes after interventions. By combining rigorous research insights with careful clinical translation, the microbiome field continues to move toward interventions that are personalized, safe, and effective.

Microbial Community Profiling: Mapping the Diversity and Abundance of Gut Microbes

Microbial community profiling is the systematic characterization of which microbes are present in a sample and in what relative amounts. Two core goals are taxonomic identification (who is there?) and functional inference (what might they be doing?). Techniques for profiling vary in resolution and cost. 16S rRNA gene sequencing targets conserved regions interspersed with variable regions in bacterial ribosomal RNA genes; it is cost-effective and suitable for broad surveys of bacterial composition, typically resolving to genus level. Shotgun metagenomic sequencing sequences all DNA fragments in the sample, enabling species- and often strain-level identification, detection of viruses and fungi, and profiling of gene content including metabolic pathways and antimicrobial resistance genes. Quantitative approaches (e.g., flow cytometry to count cells, spike-in standards, or qPCR for total bacterial load) complement relative abundance data so you can estimate absolute abundances rather than purely compositional percentages. Profiling pipelines produce diversity metrics: richness (number of distinct taxa), evenness (distribution of abundances), and computed indices like Shannon or Simpson. Beta diversity analyses (e.g., Bray-Curtis dissimilarity or UniFrac distances) allow comparisons across samples or groups to detect clustering related to diet, disease, or other variables. Interpreting these profiles requires ecological perspective — for instance, a bloom in opportunistic taxa after antibiotic treatment might reflect loss of competitive inhibition rather than an exogenous pathogen. Determining beneficial versus harmful microbes involves current biological knowledge: Bifidobacterium and Faecalibacterium are often associated with health-promoting functions (fiber fermentation and butyrate production), while elevated levels of Enterobacteriaceae or certain Clostridium species may occur in dysbiosis. However, taxa can have context-dependent roles; some strains within a species are beneficial while others are pathogenic. Practical applications of profiling include informing dietary planning (e.g., increasing fermentable fibers to support butyrate-producing bacteria), guiding probiotic choices that contain strains shown to confer specific benefits, and monitoring responses to interventions such as dietary changes, antibiotics, or probiotics. For clinical or research use, ensure profiling results are interpreted alongside metadata like recent antibiotic use, travel, or gastrointestinal symptoms. When choosing a consumer profiling service, review whether the report provides practical recommendations, references to peer-reviewed evidence, and access to raw data for independent analysis. Services like the InnerBuddies microbiome test aim to simplify profiling for non-specialists while providing interpretable summaries that can feed into personalized nutrition and lifestyle adjustments. Community profiling is a foundational tool — by mapping diversity and abundance you create the baseline needed to test hypotheses, measure responses, and design interventions that respect the ecological complexity of the gut.

Microbiome Sequencing Techniques: Powering Accurate and Comprehensive Gut Analysis

Sequencing technologies are central to modern microbiome investigation. Two dominant approaches are 16S rRNA gene sequencing and shotgun metagenomics. 16S sequencing amplifies conserved ribosomal gene regions with PCR primers, producing amplicons that are sequenced and clustered into operational taxonomic units (OTUs) or amplicon sequence variants (ASVs). ASVs, produced by denoising algorithms like DADA2, give finer resolution and reproducibility across studies. Advantages of 16S include lower cost, simpler computational demands, and established analytic pipelines, making it suitable for large cohorts and initial surveys. Limitations include relatively low taxonomic resolution (often to genus level), inability to detect viruses or most fungi, and limited direct functional inference because gene content is not measured. Shotgun metagenomic sequencing sequences random DNA fragments, enabling comprehensive detection of bacteria, archaea, viruses, fungi, and plasmids, and allowing reconstruction of gene catalogs and metabolic pathways. Metagenomics supports strain-level resolution with sufficient sequencing depth and provides data on antibiotic resistance genes and virulence factors. Drawbacks are higher cost, larger storage and computational requirements, and complexity in assembly and binning workflows. Beyond DNA sequencing, metatranscriptomics sequences RNA to capture gene expression profiles of the community, revealing which genes are actively transcribed. Metaproteomics and metabolomics measure proteins and metabolites respectively, offering direct evidence of functional activity. Robust microbiome analysis relies on careful experimental design: sample size and power calculations, randomized interventions for causal inference, longitudinal sampling for dynamics, and appropriate controls including negative extraction controls and mock communities to detect contamination and assess pipeline performance. Bioinformatics is a critical bottleneck — choices about read trimming, reference databases, taxonomic classifiers, and normalization methods influence results. Transparency about methods and access to raw data encourage reproducibility. For consumer testing, look for platforms that document sequencing depth, regions targeted (for 16S), and typical turnaround times. The trade-offs between techniques hinge on goals and budget: exploratory surveys may use 16S while clinically or scientifically driven projects that require functional insight should consider metagenomics. For those seeking an accessible route to gut microbiome information, the InnerBuddies microbiome test offers a practical option combining user-friendly kits with interpretive reports; for detailed research applications, partner with sequencing centers that support shotgun metagenomics and multi-omics integration. Ultimately, sequencing techniques provide the raw material for understanding gut ecology, but meaningful interpretation depends on integrating technical knowledge, clinical context, and ecological reasoning.

Probiotic Microbiome Development: Enhancing Your Gut Ecosystem Through Targeted Interventions

Probiotics, prebiotics, synbiotics, and dietary interventions are principal tools for shaping the gut microbiome. Probiotics are live microorganisms which, when administered in adequate amounts, confer health benefits to the host. Common probiotic genera include Lactobacillus, Bifidobacterium, Saccharomyces (a beneficial yeast), and certain strains of Enterococcus and Bacillus. Prebiotics are selectively fermentable substrates (typically fibers like inulin, fructooligosaccharides, and resistant starches) that nourish beneficial microbes, promoting metabolites such as butyrate and propionate. Synbiotics combine probiotics and prebiotics to support probiotic survival and functional activity. Microbiome-informed probiotic development starts with baseline profiling: identifying deficits in beneficial taxa or overrepresentation of opportunistic microbes. For instance, low levels of butyrate-producers such as Faecalibacterium prausnitzii may lead to targeted strategies that include dietary fibers to stimulate these endogenous microbes rather than attempting to replace them directly, since many beneficial gut anaerobes are difficult to formulate as probiotics. Evidence supports specific probiotic strains for defined outcomes: Lactobacillus rhamnosus GG has robust data for reducing duration of some childhood diarrheas; Bifidobacterium infantis 35624 has evidence in IBS symptom modulation; multi-strain formulations have been studied for antibiotic-associated diarrhea and some metabolic endpoints. However, efficacy is strain-specific and dose-dependent, so product selection should be evidence-based. Personalized probiotic strategies may combine a probiotic with prebiotic substrates tailored to the host’s diet and microbial profile — for example, choosing fibers that preferentially feed the taxa you want to grow. The goal of probiotic microbiome development isn’t always to permanently colonize the gut; many probiotics transiently modulate function and host responses while being consumed. Long-term ecological change is more reliably achieved through sustained dietary change (high diversity of plant fibers, reduced processed foods) and lifestyle adjustments. Safety considerations include ensuring probiotic strains are well-characterized, produced under good manufacturing practice (GMP), and free from transmissible antibiotic resistance genes. Immunocompromised individuals should consult clinicians before taking live microbes. Practical tips for incorporating probiotics: choose products with documented strains and doses, follow storage instructions (refrigeration when required), and combine with dietary changes to support engraftment and function. Track outcomes with repeat microbiome testing and symptom logs to assess response; an initial and follow-up test such as those offered by consumer services can quantify changes over weeks to months. For people wanting an integrated testing-and-intervention approach, services like InnerBuddies provide accessible testing to establish a baseline, facilitating targeted dietary and probiotic recommendations. Building a resilient gut ecosystem typically requires iterative personalization: profile, intervene, measure, and adjust. With careful selection of evidence-based strains, supportive prebiotics, and attention to diet and medication use, you can develop a probiotic-informed strategy that enhances microbiome function and supports long-term gut health.

Choosing and Using a Gut Microbiome Test: Practical Considerations

Selecting a gut microbiome test involves evaluating purpose, methodology, and downstream utility. First, define your objective: Are you seeking general wellness insights, clinical diagnostic support, or research-grade data? Consumer-oriented tests focus on accessible interpretation and lifestyle recommendations, while clinical/research labs provide deeper data and often raw data access for custom analysis. Check the sample collection method: reliable kits provide clear instructions, stabilization buffers (if needed), and tamper-evident packaging. The temporal stability of the microbiome means a single snapshot can be informative but combining baseline and follow-up tests is ideal for measuring change. Consider the laboratory methods reported by the provider: do they use 16S sequencing, shotgun metagenomics, or targeted qPCR? Verify that the lab uses validated protocols and appropriate quality controls such as negative controls and internal standards. Turnaround time, data reporting format, and availability of expert interpretive support (dietitians, microbiome specialists) are practical differentiators; some services offer consults to discuss results. Cost and data ownership matter: confirm whether you will have access to raw FASTQ or abundance tables for external analysis, and read the privacy policy regarding data use for research or aggregated reporting. Beware of overpromising claims; high-quality services will transparently state limitations and avoid deterministic health assertions. For purchasing decisions, consider scientifically oriented products such as the InnerBuddies gut microbiome test, which packages convenient sampling with actionable reporting for consumers seeking to improve diet and lifestyle based on microbiome insights. If you are using the test to guide specific interventions (e.g., initiating probiotic therapy), ensure that recommended interventions are evidence-based and discuss with a healthcare provider before changing medications or treatments. For research purposes, choose providers that share raw data and permit reproducible workflows so that statistical analyses can be conducted independently. Finally, interpret results within context: microbiome composition is influenced by short-term factors like recent meals or antibiotics, so pair testing with careful metadata collection (diet logs, medication history, travel, stress levels) to improve interpretability. When used thoughtfully, gut microbiome testing can be a practical tool for personalized health optimization and research discovery.

Designing a Study or Personal Plan: From Sampling to Intervention

Designing a microbiome investigation — whether for an academic study or a personal improvement plan — benefits from the same rigorous principles. Start with a clear hypothesis or objective, then choose appropriate sampling frequency, sample types, and analytic depth. For population-level research, plan for sufficient sample size and consider stratification by confounders like age, sex, BMI, medication use, and diet. For personal plans, baseline and multiple follow-up samples capture temporal dynamics and response to interventions. Standardize collection timing relative to meals, bowel movements, and medications to reduce noise. If you aim to measure the effect of a dietary change, incorporate a run-in baseline period, intervention period, and washout as needed. Randomization and blinding strengthen inference in formal trials; for personal experiments, employ crossover designs when feasible to control for inter-individual variability. Metadata collection is essential: record diet (preferably with quantitative logs or validated questionnaires), sleep, exercise, antibiotics and other drugs, travel, and symptoms. In the lab, choose sequencing depth based on goals: deeper sequencing improves detection of low-abundance taxa and resolution of functional genes. For interventions, combine microbiome profiling with metabolic readouts such as blood markers (glucose, lipids), fecal metabolites, or symptom scales to link microbiome shifts to clinically meaningful outcomes. When selecting interventions, prioritize evidence-based measures: increase dietary fiber diversity, reduce ultraprocessed foods, consider specific probiotic strains with demonstrated benefit, and cautiously use prebiotics to stimulate target taxa. Monitor for side effects (bloating, gas) that sometimes accompany prebiotic or probiotic use; adjust dosing when needed. If testing commercially, select a validated kit — for example many users choose accessible options like the InnerBuddies microbiome test to obtain baseline profiles and track changes after dietary or supplement interventions. Data analysis should predefine primary and secondary outcomes, use appropriate normalization for compositional data (e.g., centered log-ratio transforms), and adjust for multiple comparisons. For small sample or single-person studies, emphasize within-subject comparisons and replicate measurements. Ethical considerations include informed consent if sharing data, and a plan for managing incidental findings. By following methodical design principles, you can generate interpretable results that inform meaningful microbiome-directed interventions.

Interpreting Results and Translating Findings into Action

Interpreting microbiome test results requires an integrative approach: combine taxonomic and functional data with clinical context and lifestyle information. Reports typically provide relative abundance charts, diversity indices, and recommendations. When assessing results, consider whether observed patterns are consistent with known influences: low diversity might be associated with recent antibiotic exposure; increased Proteobacteria may signal instability or inflammation; reduced abundance of fiber-fermenting taxa could indicate a low-fiber diet. Use functional inferences from metagenomic or inferred metagenomic tools (like PICRUSt for 16S-based predictions) to identify deficits in pathways such as butyrate synthesis, bile acid metabolism, or vitamin biosynthesis. Translating findings into action follows predictable steps: identify modifiable drivers (diet, medication, stress), select interventions with evidence for addressing the specific feature (e.g., increasing fermentable fibers to raise butyrate producers), and implement monitoring plans. Probiotic selection should target strains supported by clinical data for your condition, and prebiotic choices should consider tolerance and specificity — some fibers disproportionately feed Bifidobacterium whereas resistant starches support butyrate producers. Lifestyle changes such as improved sleep, regular exercise, and reduced use of unnecessary antibiotics contribute to long-term microbiome resilience. For individuals, pairing a validated consumer test — for example, ordering a gut microbiome test like the InnerBuddies microbiome test — with professional guidance (nutritionists or clinicians with microbiome expertise) can improve the translation of results into actionable and safe plans. Importantly, expect gradual change: ecosystem-level shifts often require weeks to months, and transient fluctuations are normal. Repeat testing after a predetermined interval (commonly 8–12 weeks following an intervention) can confirm trends. Avoid overinterpretation of single microbial markers; prefer ecosystem-level patterns and measurable clinical outcomes. When results show potential pathogens or clinically actionable findings, consult healthcare professionals for further diagnostic confirmation and treatment. Finally, contribute to collective knowledge by considering anonymized data sharing or participation in research projects when appropriate; aggregated datasets improve our capacity to interpret individual results in population context. Thoughtful interpretation transforms microbiome data from descriptive lists of microbes into a roadmap for personalized, evidence-based health strategies.

Conclusion

Investigating the gut microbiome combines ecological thinking with contemporary laboratory and computational methods to reveal how microbial communities shape health. From careful sample collection and selection of sequencing methods to rigorous study design and interpretation that accounts for diet, medications, and lifestyle, a systematic approach yields actionable insights. Consumer-friendly testing platforms like the InnerBuddies gut microbiome test make baseline profiling accessible, while research and clinical pipelines offer deeper functional resolution. Translating microbiome findings into interventions — dietary fiber diversification, targeted probiotics and prebiotics, and lifestyle changes — requires evidence-based choices and iterative measurement to track outcomes. Ethical considerations, data privacy, and realistic expectations are central: microbiome science is young and growing, so integrate results with clinical judgment and established healthcare guidance. By following the structured methods described here, investigators, clinicians, and informed consumers can responsibly explore the microbiome’s potential to support personalized health improvements and contribute to advancing scientific knowledge.

Q&A Section

Q: What is the single best test to investigate the gut microbiome? A: There is no single “best” test for every purpose. For broad taxonomic surveys and affordable screening, 16S rRNA gene sequencing is common. For species- and strain-level identification and functional gene analysis, shotgun metagenomic sequencing is superior. Consumer tests that combine accessible sampling and clear interpretation, such as the InnerBuddies microbiome test, can be an excellent first step for personal health decisions. Choose the test that matches your goals, budget, and need for granularity. Q: How should I prepare for a gut microbiome test? A: Follow kit instructions closely. Avoid starting new antibiotics, probiotics, or dramatic dietary changes in the days to weeks before sampling unless the study design requires it. Note recent medications, meals, travel, and health events in supporting metadata to aid interpretation. Q: Can probiotics permanently change my microbiome? A: Some probiotics colonize transiently and exert benefits while consumed; permanent engraftment is less common and depends on the strain and the host environment. Long-term dietary changes and lifestyle adjustments are more likely to produce sustained community shifts. Q: Are microbiome results clinically actionable? A: For certain conditions and well-studied interventions, microbiome data can guide management (for instance, in recurrent C. difficile infection where FMT is evidence-based). For most wellness scenarios, microbiome results inform lifestyle and dietary adjustments rather than deterministic medical decisions; always consult healthcare professionals for clinical conditions. Q: Is my microbiome test data private? A: Check the provider’s privacy policy. Reputable services clarify data ownership, consent for research use, and options for raw data access. If privacy is a priority, choose providers with strong data protections and opt-out options for research data sharing. Q: How often should I repeat testing? A: For most interventions, retesting after 8–12 weeks is reasonable to measure changes. For research requiring temporal resolution, sample more frequently during interventions and include baseline and washout periods. Q: How do I choose probiotics based on a test? A: Look for evidence-based strains tied to your goal (e.g., specific strains for IBS or antibiotic-associated diarrhea). Use test results to identify functional deficits (e.g., low fiber fermenters) and select prebiotics or synbiotics accordingly. Q: Where can I buy a convenient gut microbiome test? A: Consider scientifically oriented consumer tests; the InnerBuddies microbiome test provides an accessible sampling kit and interpretive reporting suitable for baseline testing and monitoring changes after interventions.

Important Keywords

microbiome, gut microbiome, gut microbiome test, microbiome testing kit, microbiome analysis, 16S rRNA sequencing, shotgun metagenomics, microbial community profiling, probiotic, prebiotic, synbiotic, microbiome sequencing, InnerBuddies microbiome test, microbiome research, stool sample analysis, metagenomics, metatranscriptomics, metabolomics, microbiome diversity

InnerBuddies gut microbiome test | gut microbiome test | microbiome testing kit | purchase gut microbiome test